Skip to main content

CORRECTION article

Front. Pharmacol., 28 November 2017
Sec. Experimental Pharmacology and Drug Discovery
Volume 8 - 2017 | https://doi.org/10.3389/fphar.2017.00890

Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice

This article is a correction to:

  1. Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice

    1. Read original article
\r\nWei Chen,Wei Chen1,2Fengchun Shui,Fengchun Shui1,2Cheng LiuCheng Liu3Xinbo Zhou,Xinbo Zhou1,2Wei Li,Wei Li1,2Zhibing Zheng,Zhibing Zheng1,2Wei FuWei Fu3Lili Wang,*Lili Wang1,2*
  • 1Beijing Institute of Pharmacology and Toxicology, Beijing, China
  • 2State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
  • 3Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China

A corrigendum on
Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice

by Xie, X., Chen, W., Zhang, N., Yuan, M., Xu, C., Zheng, Z., et al. (2017). Front. Pharmacol. 8:707. doi: 10.3389/fphar.2017.00707

There is an error in the Funding statement. The correct number for the Major Program of the Ministry of Science and Technology of China is 2012ZX09301-001, 2012ZX09301-003.

In the original article, we neglected to include the funder the National Natural Science Foundation of China, 81430090 to LW.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: CB1R antagonist, obesity, periphery, blood–brain-barrier

Citation: Chen W, Shui F, Liu C, Zhou X, Li W, Zheng Z, Fu W and Wang L (2017) Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice. Front. Pharmacol. 8:890. doi: 10.3389/fphar.2017.00890

Received: 08 November 2017; Accepted: 20 November 2017;
Published: 28 November 2017.

Edited and reviewed by: Ming Wang, Phanes Therapeutics, United States

Copyright © 2017 Chen, Shui, Liu, Zhou, Li, Zheng, Fu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lili Wang, wangll63@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.